Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Nektar Therapeutics (NASDAQ:NKTR)

19.50
Delayed Data
As of Jun 22
 +0.34 / +1.77%
Today’s Change
11.41
Today|||52-Week Range
24.88
+58.92%
Year-to-Date

Today’s Trading

Previous close19.16
Today’s open19.23
Day’s range19.01 - 19.91
Volume966,482
Average volume (3 months)1,918,300
Market cap$3.0B
Dividend yield--
Data as of 06/22/2017

Growth & Valuation

Earnings growth (last year)-80.33%
Earnings growth (this year)-13.51%
Earnings growth (next 5 years)-7.38%
Revenue growth (last year)-28.32%
P/E ratioNM
Price/Sales10.35
Price/Book33.31

Competitors

 Today’s
change
Today’s
% change
XONIntrexon Corp+1.34+5.59%
JUNOJuno Therapeutics In...+0.55+2.08%
AVXSAveXis Inc+0.74+0.97%
HALOHalozyme Therapeutic...+0.24+1.64%
Data as of 06/22/2017

Financials

Next reporting dateAugust 10, 2017
EPS forecast (this quarter)-$0.36
Annual revenue (last year)$165.4M
Annual profit (last year)-$153.5M
Net profit margin-92.80%

Profile

Sector
Health Technology
Industry
Biotechnology
President, Chief Executive Officer &
Director
Howard W. Robin
Chief Operating Officer &
Senior Vice President
John Nicholson
Corporate headquarters
San Francisco, California

Forecasts